Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, USA.
Ann Surg Oncol. 2010 Jun;17(6):1515-29. doi: 10.1245/s10434-010-0935-1. Epub 2010 Feb 12.
We sought to reduce local recurrence for retroperitoneal sarcomas by using a coordinated strategy of advanced radiation techniques and aggressive en-bloc surgical resection.
Proton-beam radiation therapy (PBRT) and/or intensity-modulated radiation therapy (IMRT) were delivered to improve tumor target coverage and spare selected adjacent organs. Surgical resection of tumor and adjacent organs was performed to obtain a disease-free anterior margin. Intraoperative electron radiation therapy (IOERT) was delivered to any close posterior margin.
Twenty patients had primary tumors and eight had recurrent tumors. Tumors were large (median size 9.75 cm), primarily liposarcomas and leiomyosarcomas (71%), and were mostly of intermediate or high grade (81%). PBRT and/or IMRT were delivered to all patients, preferably preoperatively (75%), to a median dose of 50 Gy. Surgical resection included up to five adjacent organs, most commonly the colon (n = 7) and kidney (n = 7). Margins were positive for disease, usually posteriorly, in 15 patients (54%). IOERT was delivered to the posterior margin in 12 patients (43%) to a median dose of 11 Gy. Surgical complications occurred in eight patients (28.6%), and radiation-related complications occurred in four patients (14%). After a median follow-up of 33 months, only two patients (10%) with primary disease experienced local recurrence, while three patients (37.5%) with recurrent disease experienced local recurrence.
Aggressive resection of retroperitoneal sarcomas can achieve a disease-negative anterior margin. PBRT and/or IMRT with IOERT may possibly deliver sufficient radiation dose to the posterior margin to control microscopic residual disease. This strategy may minimize radiation-related morbidity and reduce local recurrence, especially in patients with primary disease.
我们试图通过采用先进的放射技术和积极的整块切除术的协调策略来降低腹膜后肉瘤的局部复发率。
质子束放射治疗(PBRT)和/或调强放射治疗(IMRT)用于改善肿瘤靶区覆盖范围并保护选定的相邻器官。进行肿瘤和相邻器官的外科切除,以获得无疾病的前切缘。对任何靠近的后切缘进行术中电子放射治疗(IOERT)。
20 名患者有原发性肿瘤,8 名患者有复发性肿瘤。肿瘤较大(中位大小 9.75cm),主要为脂肪肉瘤和平滑肌肉瘤(71%),且大多为中高级别(81%)。所有患者均接受了 PBRT 和/或 IMRT 治疗,最好是术前(75%),中位剂量为 50Gy。外科切除包括多达五个相邻器官,最常见的是结肠(n=7)和肾脏(n=7)。15 名患者(54%)的后切缘有疾病阳性,通常为阳性。12 名患者(43%)在后切缘接受了 IOERT,中位剂量为 11Gy。8 名患者(28.6%)发生手术并发症,4 名患者(14%)发生放射相关并发症。中位随访 33 个月后,仅 2 名原发性疾病患者(10%)发生局部复发,3 名复发性疾病患者(37.5%)发生局部复发。
积极切除腹膜后肉瘤可获得无疾病的前切缘。PBRT 和/或 IMRT 联合 IOERT 可能在后切缘提供足够的放射剂量来控制微观残留疾病。这种策略可能会最大限度地减少放射相关的发病率并降低局部复发率,尤其是在原发性疾病患者中。